Bladder cancerMACA CANCER INFORMATION GUIDE
Understanding bladder cancer.
What bladder cancer is, why blood in the urine should always be checked, how the cancer is diagnosed and staged, and the treatments your care team may discuss with you.
What is bladder cancer?
Bladder cancer begins when cells in the lining of the bladder grow out of control and form a tumour. Some bladder cancers stay in the inner lining. Others grow deeper into the bladder wall, and from there they can spread to nearby lymph nodes and to other parts of the body.
How the bladder works
The bladder is a hollow, stretchy organ in the lower part of the abdomen (the pelvis). Its job is to store urine. The kidneys filter waste from the blood to make urine, which travels down two thin tubes called ureters into the bladder. When you pass urine, the muscle in the bladder wall squeezes and pushes the urine out through another tube, the urethra.
The bladder wall has several layers. The inner lining is called the urothelium. Beneath it is a layer of connective tissue, then a thick layer of muscle, and on the outside a layer of fatty tissue. Most bladder cancers start in the inner lining. How far a cancer has grown into these layers, and especially whether it has reached the muscle, is one of the most important things for deciding treatment.
How common is bladder cancer?
About 614,000 people around the world were diagnosed with bladder cancer in 2022, and about 220,000 died from it, according to GLOBOCAN 2022 estimates. It is more than three times as common in men as in women, and it becomes more common with age.
In parts of Africa and the Middle East, bladder cancer has a different pattern from the rest of the world. A long-term infection called schistosomiasis (bilharzia) is an important cause, and these cancers can affect people at a younger age. This guide explains why.
Signs and symptoms
The most common sign of bladder cancer is blood in the urine. Doctors call this haematuria. The urine may look pink, red, rusty or the colour of cola. Sometimes the blood comes and goes: it may appear once and then not again for weeks or months. Sometimes there is too little to see and it is only found when the urine is tested.
Other symptoms can include:
- Needing to pass urine more often than usual, including at night
- Pain or burning when passing urine
- Feeling a sudden or urgent need to pass urine, even when the bladder is not full
When bladder cancer is larger or has spread, it may cause:
- Being unable to pass urine
- Pain in the lower back on one side, or in the abdomen
- Pain in the bones
- Swelling of the feet
- Losing weight without trying, loss of appetite and tiredness
These symptoms are much more often caused by other conditions, such as urinary infections, kidney stones, an enlarged prostate or bilharzia. But they should always be checked.
Risk factors
A risk factor is anything that increases your chance of getting a disease. Having a risk factor does not mean you will get bladder cancer, and some people who get it have no known risk factor. Things that increase the risk include:
- Smoking: the most important cause worldwide. People who smoke are at least three times as likely to get bladder cancer as people who do not, and smoking causes about half of all bladder cancers. Harmful chemicals from tobacco pass into the urine and sit against the bladder lining.
- Schistosomiasis (bilharzia): a long-term infection with a parasitic worm called Schistosoma haematobium, which lives in the blood vessels around the bladder. It is a known cause of bladder cancer, especially the squamous cell type (see below).
- Chemicals at work: chemicals called aromatic amines and some other substances used in making dyes, rubber, leather, textiles, paint and printing products. Painters, machinists, printers, hairdressers, truck drivers and firefighters may also have a higher risk. The cancer can develop many years after exposure, and smoking adds to the risk.
- Long-term irritation of the bladder: repeated urinary infections, bladder stones and a urinary catheter left in place for a long time are linked to bladder cancer, particularly the squamous cell type.
- Arsenic in drinking water: in some parts of the world, drinking water with high levels of arsenic increases the risk.
- Some medicines and earlier treatment: long-term use of the chemotherapy medicine cyclophosphamide, and previous radiotherapy to the pelvis for another cancer.
- Age and sex: the risk rises with age, and men are affected much more often than women.
- Family history: having close relatives who have had bladder cancer slightly raises the risk.
Bilharzia and bladder cancer
Bilharzia is common in many parts of Africa. The World Health Organization estimates that at least 93.9% of people who need treatment for schistosomiasis live in Africa. People become infected when tiny larvae of the parasite, released by freshwater snails, pass through the skin during contact with infected water in rivers, lakes, ponds and irrigation channels, for example while farming, fishing, washing or swimming.
The worms lay eggs that lodge in the bladder wall. Over many years, the body’s reaction to the eggs causes long-lasting inflammation and scarring, which can lead to cancer. The classic sign of bilharzia of the urinary tract is blood in the urine. Infection often begins in childhood, and the cancer may appear decades later.
Early detection and prevention
There is no routine screening test for bladder cancer for people who have no symptoms. Major medical organisations do not recommend screening most people. Instead, bladder cancer is usually found early when people act quickly on blood in the urine or other urinary symptoms.
Act on blood in the urine
Bladder cancers found while they are still in the inner lining of the bladder are usually easier to treat, and the bladder can often be kept. A cancer that has grown into the muscle needs bigger treatment. Seeing a health worker promptly about blood in the urine is the most important thing you can do. If the first treatment you are given does not stop the bleeding, go back.
Lowering your risk
- Do not smoke: and if you smoke, stopping lowers your risk over time. Ask your health worker about help to stop.
- Get bilharzia treated: bilharzia is treated with a medicine called praziquantel. In many areas it is given to schoolchildren and communities through public health programmes. If you have had blood in your urine or have been in contact with water where bilharzia is common, ask a health worker about testing and treatment.
- Protect yourself at work: if you work with industrial chemicals, follow safety rules and use the protective equipment provided.
- Drink enough water: people who drink more fluids each day tend to have lower rates of bladder cancer, possibly because chemicals are cleared from the bladder more often.
Types of bladder cancer
By the type of cell
- Urothelial carcinoma: also called transitional cell carcinoma. It starts in the cells of the bladder lining and is by far the most common type in most of the world.
- Squamous cell carcinoma: starts in thin, flat cells that can form in the bladder lining after long-term irritation or infection. In the United States it makes up only about 3–5% of bladder cancers, but it is much more common where bilharzia is common, mainly in Africa and the Middle East. It is often found at a later stage.
- Adenocarcinoma: starts in gland-forming cells. It is rare, about 1–2% of bladder cancers.
- Small cell carcinoma and sarcoma: very rare types that are treated differently.
In Nigeria, hospital studies have found that squamous cell carcinoma has been the most common type in some northern centres, while urothelial carcinoma has been more common in some southern centres. Researchers say more studies are needed to understand these patterns.
By how deep the cancer has grown
- Non-muscle-invasive bladder cancer: the cancer is in the inner lining or the connective tissue just beneath it, but has not reached the muscle layer. It can often be treated while keeping the bladder, but it often comes back, so regular check-ups are important.
- Muscle-invasive bladder cancer: the cancer has grown into the muscle layer of the bladder wall or beyond. It is more likely to spread and needs more intensive treatment.
By how the tumour grows
- Papillary tumours: grow in thin, finger-like shapes from the lining towards the hollow centre of the bladder.
- Flat tumours (carcinoma in situ): lie flat on the lining. Carcinoma in situ is high grade, which means it is more likely to grow into the bladder wall if it is not treated.
The grade describes how abnormal the cancer cells look under a microscope. Low-grade cancers tend to grow slowly. High-grade cancers are more likely to come back and to grow into the muscle.
Diagnosis
If you have blood in your urine or other urinary symptoms, your doctor will ask about your health, smoking, work and whether you have had bilharzia. They will examine you and may then arrange the following tests.
Urine tests
- Urinalysis: checks a urine sample for blood, infection and, in some areas, bilharzia eggs.
- Urine cytology: looks at urine under a microscope for cancer cells.
Cystoscopy
Cystoscopy is the main test for bladder cancer. A thin tube with a light and a camera (a cystoscope) is passed through the urethra into the bladder, so the doctor can look at the lining. It is usually done with a local anaesthetic gel to numb the urethra. If anything abnormal is seen, a sample (biopsy) can be taken.
Transurethral resection of bladder tumour (TURBT)
If a tumour is found, it is usually removed in an operation called a TURBT, under a general or spinal anaesthetic. Instruments are passed through the urethra, so there is no cut in the skin. The surgeon removes the tumour and some of the muscle beneath it. A pathologist then examines the tissue to find the type and grade of cancer and whether it has reached the muscle. For many early cancers, the TURBT is both the diagnosis and the first treatment. A second TURBT is sometimes done a few weeks later.
Scans
- CT urogram: a CT scan of the kidneys, ureters and bladder, taken after a dye is injected into a vein. It checks the whole urinary tract.
- Ultrasound: uses sound waves to look at the kidneys and bladder. It is widely available and is often an early test.
- CT, MRI or bone scans: may be used to see how deeply the cancer has grown and whether it has spread to lymph nodes, bones or other organs.
Stages and outlook
The stage describes how far the cancer has grown into the bladder wall, whether it has reached nearby lymph nodes and whether it has spread to other parts of the body (TNM).
- Stage 0a: a papillary tumour in the inner lining that has not grown into the bladder wall.
- Stage 0is: a flat cancer (carcinoma in situ) in the inner lining only.
- Stage I: the cancer has grown into the connective tissue beneath the lining, but not into the muscle.
- Stage II: the cancer has grown into the muscle layer of the bladder wall, but not through it.
- Stage III: the cancer has grown through the muscle into the surrounding fat or nearby organs such as the prostate, womb or vagina, or has spread to lymph nodes in the pelvis.
- Stage IV: the cancer has reached the wall of the pelvis or abdomen, or has spread to distant lymph nodes or to organs such as the bones, liver or lungs.
Stages 0 and I are non-muscle-invasive. Stages II and III are muscle-invasive.
Outlook
The outlook depends mainly on the stage, the type and grade of the cancer, your general health and access to treatment. Figures from the United States for people diagnosed in 2015–2021 show how much the stage matters: about 98% of people whose cancer was only in the inner lining were alive five years after diagnosis, compared with about 73% when the cancer had grown deeper but stayed in the bladder, about 41% when it had spread to nearby tissues or lymph nodes, and about 9% when it had spread to distant parts of the body. These figures may be different in other countries and cannot predict what will happen to any one person.
Squamous cell cancers linked to bilharzia are often found at a later stage. Seeing a health worker early about blood in the urine is the best way to find bladder cancer when it is most treatable.
Treatment
Treatment depends on the type, grade and stage of the cancer, whether it has reached the muscle, your general health and your own preferences. A team that may include urologists (surgeons who treat the urinary system), oncologists, radiologists, pathologists and nurses plans it with you.
Non-muscle-invasive bladder cancer
- TURBT: removing the tumour through the urethra is the main treatment. A single dose of chemotherapy may be put into the bladder soon afterwards to lower the chance of the cancer coming back.
- Intravesical chemotherapy: medicines such as mitomycin or gemcitabine are passed into the bladder through a thin tube (catheter), where they act on the lining for a short time before you pass them out in your urine.
- BCG: BCG is a weakened form of the bacteria used in the tuberculosis vaccine. Put into the bladder through a catheter, it causes the immune system to attack cancer cells in the lining. It is usually given once a week for six weeks, often followed by top-up (maintenance) treatments. It is used for cancers with a higher risk of coming back or growing.
- Cystectomy: removing the bladder may be advised for very high-risk cancers, or if the cancer keeps coming back after other treatment.
Muscle-invasive bladder cancer
- Chemotherapy before surgery: chemotherapy that includes cisplatin is often given first. It can shrink the cancer and treat cancer cells that may have spread, and it helps people live longer than surgery alone.
- Radical cystectomy: the whole bladder and nearby lymph nodes are removed. In men, the prostate and seminal vesicles are usually removed too. In women, the womb, ovaries and part of the vagina may be removed. A partial cystectomy, removing only part of the bladder, is possible for a few people.
- Bladder-sparing treatment: for some people, the bladder can be kept by combining a thorough TURBT with radiotherapy and chemotherapy given together (chemoradiation). This may suit people who cannot have, or do not want, a cystectomy. It needs regular cystoscopies afterwards.
Urinary diversion
If the bladder is removed, the surgeon makes a new way for urine to leave the body, usually using a short piece of bowel.
- Ileal conduit (urostomy): urine drains through an opening on the abdomen, called a stoma, into a bag that is worn all the time.
- Continent pouch: an internal pouch stores urine, which you drain several times a day by passing a catheter through a small opening on the abdomen. No bag is needed.
- Neobladder: a new bladder is made from bowel and joined to the urethra, so you can pass urine in the usual way, on a schedule.
Advanced bladder cancer
When the cancer has spread, treatment aims to control it, ease symptoms and help you live well for longer. It may include chemotherapy, immunotherapy (medicines such as pembrolizumab that help the immune system attack the cancer) and targeted medicines such as enfortumab vedotin. Radiotherapy can help with bleeding or pain. Not every medicine is available in every country, so ask your team what is available to you.
Clinical trials
Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.
What taking part involves
- Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
- Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
- You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
- Taking part is voluntary. You can leave a trial at any point and still receive standard care.
Finding a trial
Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:
- Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
- WHO International Clinical Trials Registry Platform: one search across registries worldwide.
- ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.
Living with and after treatment
Side effects
Side effects depend on the treatment and often improve once it ends. They may include:
- Blood in the urine and pain when passing urine for a short time after a TURBT
- Needing to pass urine often, burning, and flu-like symptoms for a day or two after BCG or chemotherapy into the bladder
- Tiredness, nausea and a higher risk of infection during chemotherapy
- Bladder irritation, diarrhoea and tiredness during radiotherapy to the pelvis
- Changes to sex and fertility after cystectomy. Ask about this before treatment starts
Living with a stoma
If you have a urostomy, a specialist stoma nurse, where available, can teach you how to care for the stoma and change the bag. Many people return to work, travel, prayer, exercise and family life. Ask your team about where to get supplies, as this can be a challenge in some areas.
Follow-up
Bladder cancer can come back, sometimes years later, so follow-up is very important. If your bladder has been kept, you will have regular cystoscopies, often every few months at first and then less often. Report any new blood in your urine or other change between appointments.
Emotional support
A diagnosis of bladder cancer, and changes such as a stoma, can affect body image, relationships, work and finances. Talking with family, friends, your care team and other people who have had bladder cancer can help.
Questions to ask your care team
- What type of bladder cancer do I have, and what is its grade and stage?
- Has the cancer grown into the muscle of the bladder wall?
- Could bilharzia have played a part, and should I or my family be tested or treated for it?
- What are my treatment options, and what is the aim of each one?
- Can I keep my bladder? If not, which type of urinary diversion would suit me?
- What side effects should I expect, and who do I contact if I have them?
- How often will I need cystoscopies and other check-ups?
- Is there a clinical trial that could be right for me?
